291
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Survivorship

Patient-reported lower limb edema after primary radiotherapy for prostate cancer

, , , , , , & show all
Pages 1279-1285 | Received 01 May 2023, Accepted 14 Jul 2023, Published online: 30 Aug 2023

References

  • Graf N, Rufibach K, Schmidt AM, et al. Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. Eur J Gynaecol Oncol. 2013;34(1):23–27.
  • Najjari Jamal D, Potter R, Haie-Meder C, et al. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: a report from the EMBRACE study. Radiother Oncol. 2018;127(3):449–455. doi:10.1016/j.radonc.2018.03.026.
  • Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937–1944. doi:10.1056/NEJMcp1803290.
  • Clinckaert A, Callens K, Cooreman A, et al. The prevalence of lower limb and genital lymphedema after prostate cancer treatment: a systematic review. Cancers (Basel). 2022;14(22):5667. doi:10.3390/cancers14225667.
  • Rasmusson E, Gunnlaugsson A, Blom R, et al. Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer. Radiat Oncol. 2013;8(1):271. doi:10.1186/1748-717X-8-271.
  • Grada AA, Phillips TJ. Lymphedema: diagnostic workup and management. J Am Acad Dermatol. 2017;77(6):995–1006. doi:10.1016/j.jaad.2017.03.021.
  • Amdur RJ, Parsons JT, Fitzgerald LT, et al. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up. Radiother Oncol. 1990;18(3):235–246. doi:10.1016/0167-8140(90)90059-6.
  • Aristizabal SA, Steinbronn D, Heusinkveld RS. External beam radiotherapy in cancer of the prostate. The university of Arizona experience. Radiother Oncol. 1984;1(4):309–315. doi:10.1016/s0167-8140(84)80018-3.
  • Borghede G, Hedelin H. Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study. Radiother Oncol. 1997;43(2):139–146. doi:10.1016/s0167-8140(96)01871-3.
  • Pilepich MV, Pajak T, George FW, et al. Preliminary report on phase III RTOG studies of extended-field irradiation in carcinoma of the prostate. Am J Clin Oncol. 1983;6(4):485–491. doi:10.1097/00000421-198308000-00017.
  • Forman JD, Zinreich E, Lee DJ, et al. Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1985;11(12):2073–2080. doi:10.1016/0360-3016(85)90086-0.
  • Perez CA, Walz BJ, Zivnuska FR, et al. Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis. Int J Radiat Oncol Biol Phys. 1980;6(5):555–563. doi:10.1016/0360-3016(80)90382-x.
  • Pilepich MV, Perez CA, Walz BJ, et al. Complications of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1981;7(10):1341–1348. doi:10.1016/0360-3016(81)90029-8.
  • Thorsteinsdottir T, Stranne J, Carlsson S, et al. LAPPRO: a prospective multicentre comparative study of robot-assisted laparoscopic and retropubic radical prostatectomy for prostate cancer. Scand J Urol Nephrol. 2011;45(2):102–112. doi:10.3109/00365599.2010.532506.
  • Gasparis AP, Kim PS, Dean SM, et al. Diagnostic approach to lower limb edema. Phlebology. 2020;35(9):650–655. doi:10.1177/0268355520938283.
  • Tobin AM, Ahern T, Rogers S, et al. The dermatological consequences of obesity. Int J Dermatol. 2013;52(8):927–932. doi:10.1111/j.1365-4632.2012.05624.x.
  • Kim M, Kim SW, Lee SU, et al. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86(3):498–503. doi:10.1016/j.ijrobp.2013.02.018.
  • Soran A, Menekse E, Girgis M, et al. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work? Support Care Cancer. 2016;24(3):1413–1419. doi:10.1007/s00520-015-2933-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.